ADMP Annual Interest Expense
N/A
31 December 2022
Summary:
ADMP annual interest expense is not available.ADMP Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP Quarterly Interest Expense
$46.30 K
0.00%
30 June 2023
Summary:
As of January 22, 2025, ADMP quarterly interest expense is $46.30 thousandOver the past year, it has increased by +$46.30 thousand (+100.00%).ADMP Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP TTM Interest Expense
$46.30 K
0.00%
30 June 2023
Summary:
As of January 22, 2025, ADMP TTM interest expense is $46.30 thousandOver the past year, it has increased by +$44.40 thousand (+2336.84%).ADMP TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ADMP Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | +100.0% | +2336.8% |
| 3 y3 years | - | +40.7% | -68.6% |
| 5 y5 years | - | -9.9% | -62.5% |
ADMP Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | ||||||
| 5 y | 5-year | ||||||
| alltime | all time | -99.1% | -99.5% |
Adamis Pharmaceuticals Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2023 | - | $46.30 K(>+9900.0%) | $46.30 K(>+9900.0%) |
| Sept 2022 | - | $0.00(0.0%) | $0.00(-100.0%) |
| June 2022 | - | $0.00(-100.0%) | $1900.00(-77.4%) |
| Sept 2021 | - | $1900.00(-34.5%) | $8400.00(+2.4%) |
| June 2021 | - | $2900.00(+52.6%) | $8200.00(-78.5%) |
| Mar 2021 | - | $1900.00(+11.8%) | $38.20 K(-48.8%) |
| Dec 2020 | $4900.00(-96.0%) | $1700.00(0.0%) | $74.60 K(-41.4%) |
| Sept 2020 | - | $1700.00(-94.8%) | $127.30 K(-13.7%) |
| June 2020 | - | $32.90 K(-14.1%) | $147.50 K(+7.2%) |
| Mar 2020 | - | $38.30 K(-29.6%) | $137.60 K(+11.6%) |
| Dec 2019 | $123.30 K(-21.9%) | $54.40 K(+148.4%) | $123.30 K(+31.3%) |
| Sept 2019 | - | $21.90 K(-4.8%) | $93.90 K(-8.6%) |
| June 2019 | - | $23.00 K(-4.2%) | $102.70 K(-21.7%) |
| Mar 2019 | - | $24.00 K(-4.0%) | $131.10 K(-16.9%) |
| Dec 2018 | $157.80 K(-31.8%) | $25.00 K(-18.6%) | $157.80 K(-14.5%) |
| Sept 2018 | - | $30.70 K(-40.3%) | $184.60 K(-10.6%) |
| June 2018 | - | $51.40 K(+1.4%) | $206.50 K(-3.7%) |
| Mar 2018 | - | $50.70 K(-2.1%) | $214.50 K(-7.3%) |
| Dec 2017 | $231.30 K(+7.9%) | $51.80 K(-1.5%) | $231.30 K(-8.0%) |
| Sept 2017 | - | $52.60 K(-11.4%) | $251.30 K(-6.5%) |
| June 2017 | - | $59.40 K(-12.0%) | $268.90 K(-4.6%) |
| Mar 2017 | - | $67.50 K(-6.0%) | $281.90 K(+31.5%) |
| Dec 2016 | $214.40 K(-5.3%) | $71.80 K(+2.3%) | $214.40 K(+50.4%) |
| Sept 2016 | - | $70.20 K(-3.0%) | $142.60 K(+97.0%) |
| June 2016 | - | $72.40 K | $72.40 K |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2014 | $226.30 K(-97.4%) | - | - |
| Sept 2014 | - | $0.00(-100.0%) | $5.67 M(-32.9%) |
| June 2014 | - | $225.90 K(+55.4%) | $8.45 M(-2.1%) |
| Mar 2014 | $8.63 M(+269.6%) | $145.40 K(-97.3%) | $8.63 M(-5.2%) |
| Dec 2013 | - | $5.30 M(+90.8%) | $9.10 M(+95.9%) |
| Sept 2013 | - | $2.78 M(+586.0%) | $4.64 M(+90.0%) |
| June 2013 | - | $404.90 K(-34.1%) | $2.44 M(+4.7%) |
| Mar 2013 | $2.33 M(+6493.2%) | $614.60 K(-27.3%) | $2.33 M(+35.5%) |
| Dec 2012 | - | $845.10 K(+45.9%) | $1.72 M(+95.8%) |
| Sept 2012 | - | $579.30 K(+96.4%) | $879.60 K(+190.4%) |
| June 2012 | - | $295.00 K(>+9900.0%) | $302.90 K(+755.6%) |
| Mar 2012 | $35.40 K(-95.2%) | $2700.00(+3.8%) | $35.40 K(-44.9%) |
| Dec 2011 | - | $2600.00(0.0%) | $64.30 K(-51.9%) |
| Sept 2011 | - | $2600.00(-90.5%) | $133.80 K(-70.2%) |
| June 2011 | - | $27.50 K(-13.0%) | $449.60 K(-39.6%) |
| Mar 2011 | $744.30 K(-72.7%) | $31.60 K(-56.2%) | $744.30 K(-76.5%) |
| Dec 2010 | - | $72.10 K(-77.4%) | $3.17 M(-5.5%) |
| Sept 2010 | - | $318.40 K(-1.2%) | $3.35 M(+10.2%) |
| June 2010 | - | $322.20 K(-86.9%) | $3.04 M(+11.7%) |
| Mar 2010 | $2.73 M(+906.6%) | $2.46 M(+853.8%) | $2.73 M(+909.7%) |
| Dec 2009 | - | $257.50 K(+3002.4%) | $270.00 K(+2060.0%) |
| Sept 2009 | - | $8300.00(+97.6%) | $12.50 K(+197.6%) |
| June 2009 | - | $4200.00(>+9900.0%) | $4200.00(>+9900.0%) |
| Mar 2009 | - | $0.00 | $0.00 |
| Dec 2008 | $270.80 K(+36.6%) | - | - |
| Dec 2007 | $198.20 K | - | - |
FAQ
- What is the all time high annual interest expense for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly interest expense?
- What is the all time high quarterly interest expense for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals quarterly interest expense year-on-year change?
- What is Adamis Pharmaceuticals TTM interest expense?
- What is the all time high TTM interest expense for Adamis Pharmaceuticals?
- What is Adamis Pharmaceuticals TTM interest expense year-on-year change?
What is the all time high annual interest expense for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high annual interest expense is $8.63 M
What is Adamis Pharmaceuticals quarterly interest expense?
The current quarterly interest expense of ADMP is $46.30 K
What is the all time high quarterly interest expense for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high quarterly interest expense is $5.30 M
What is Adamis Pharmaceuticals quarterly interest expense year-on-year change?
Over the past year, ADMP quarterly interest expense has changed by +$46.30 K (+100.00%)
What is Adamis Pharmaceuticals TTM interest expense?
The current TTM interest expense of ADMP is $46.30 K
What is the all time high TTM interest expense for Adamis Pharmaceuticals?
Adamis Pharmaceuticals all-time high TTM interest expense is $9.10 M
What is Adamis Pharmaceuticals TTM interest expense year-on-year change?
Over the past year, ADMP TTM interest expense has changed by +$44.40 K (+2336.84%)